Answers are grounded in this paper and cite their sources.
ICOS is a useful molecule for identifying T(FH) cells and its restricted expression to angioimmunoblastic T-cell lymphoma and a proportion of peripheral T-cell lymphomas, not otherwise specified (showing a T(FH)-like profile) suggests its inclusion in the antibody panel for diagnosing T(FH)-derived lymphomas. Our findings provide further evidence that the histological spectrum of T(FH)-derived lymphomas is broader than previously assumed.
No takes yet. Share an insight, caveat, or question.
Marafioti et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: